Table 1

Relation between study parameters and results

Study		Time of randomisation/ primary therapy		Patients randomised with first bleed (%)		Patients with Child class C cirrhosis (%)		Rebleeding (%)		Mortality (%)		Patients needing “TIPSS rescue”
Study		Time of randomisation/ primary therapy		Patients randomised with first bleed (%)		Patients with Child class C cirrhosis (%)		ES	TIPSS	ES	TIPSS	Patients needing “TIPSS rescue”
Cabrera and colleagues¹ (TIPSS, n=31; ES, n=32)	<3 days	68	10	51	23		16	19	28% (9 patients)
Rossle and colleagues² (TIPSS, n=61; ES, n=65)	<24 hours	39	18	45	15		13	12	14% (9 patients)
Cello and colleagues³ (TIPSS, n=24; ES, n=25)	<24 hours	NS	NS	48	12		16	12	24% (6 patients)
Sanyal and colleagues⁴ (TIPSS, n=41; ES, n=39)	?9–11 days	44	49	26	24		29	18	21% (8 patients)
Jalan and colleagues⁵ (TIPSS, n=41; ES, n=39)1-150	24 hours	100	48	52	10		37	42	30% (8 patients)
Merli and colleagues⁶ (TIPSS, n=38; ES, n=43)	3 strata; <1 week, 1–6 weeks, 6 weeks to 6 months	62	12	19	24		19	24	14% (6 patients)
Sauer and colleagues⁷ (TIPSS, n=42; ES, n=41)	1–3 days	100	24	57	23		31	33	12% (5 patients)
Garcia-Villareal and colleagues⁸ (TIPSS, n=22; ES, n=24)	24 hours	80	30	50	9		33	15	5% (1 patient, 6 patients died before rescue)

↵1-150 Endoscopic treatment: variceal band ligation.
TIPSS, transjugular intrahepatic portosystemic stent-shunt; ES, endoscopic sclerotherapy; NS, not stated.